Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
ACHC vs UHS vs SEM vs SGRY vs BKD
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
ACHC vs UHS vs SEM vs SGRY vs BKD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $2.33B | $10.55B | $2.04B | $1.89B | $3.37B |
| Revenue (TTM) | $3.37B | $17.76B | $5.52B | $3.34B | $3.11B |
| Net Income (TTM) | $-1.11B | $1.52B | $134M | $-76M | $-205M |
| Gross Margin | 56.2% | 67.6% | 10.6% | 22.8% | 13.5% |
| Operating Margin | 11.7% | 11.5% | 5.8% | 11.8% | 1.3% |
| Forward P/E | 17.0x | 7.2x | 13.1x | 38.7x | — |
| Total Debt | $2.65B | $5.51B | $3.70B | $4.02B | $6.66B |
| Cash & Equiv. | $133M | $138M | $27M | $240M | $279M |
ACHC vs UHS vs SEM vs SGRY vs BKD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Acadia Healthcare C… (ACHC) | 100 | 88.4 | -11.6% |
| Universal Health Se… (UHS) | 100 | 159.8 | +59.8% |
| Select Medical Hold… (SEM) | 100 | 189.1 | +89.1% |
| Surgery Partners, I… (SGRY) | 100 | 108.8 | +8.8% |
| Brookdale Senior Li… (BKD) | 100 | 387.4 | +287.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ACHC vs UHS vs SEM vs SGRY vs BKD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ACHC lags the leaders in this set but could rank higher in a more targeted comparison.
UHS carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 9.7%, EPS growth 37.3%, 3Y rev CAGR 9.0%
- Lower volatility, beta 0.60, Low D/E 74.3%, current ratio 1.05x
- 9.7% revenue growth vs BKD's 4.8%
- Better valuation composite
SEM is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 0 yrs, beta 0.46, yield 1.5%
- 163.0% 10Y total return vs UHS's 30.4%
- Beta 0.46, yield 1.5%, current ratio 1.04x
- Beta 0.46 vs SGRY's 1.04
Among these 5 stocks, SGRY doesn't own a clear edge in any measured category.
BKD ranks third and is worth considering specifically for momentum.
- +110.1% vs SGRY's -36.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% revenue growth vs BKD's 4.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 8.6% margin vs ACHC's -32.8% | |
| Stability / Safety | Beta 0.46 vs SGRY's 1.04 | |
| Dividends | 0.5% yield, 1-year raise streak, vs SEM's 1.5%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +110.1% vs SGRY's -36.6% | |
| Efficiency (ROA) | 9.8% ROA vs ACHC's -18.6%, ROIC 12.3% vs 5.9% |
ACHC vs UHS vs SEM vs SGRY vs BKD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ACHC vs UHS vs SEM vs SGRY vs BKD — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
UHS leads in 2 of 6 categories
BKD leads 1 • SEM leads 1 • ACHC leads 0 • SGRY leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
UHS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UHS is the larger business by revenue, generating $17.8B annually — 5.7x BKD's $3.1B. UHS is the more profitable business, keeping 8.6% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, UHS holds the edge at +9.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.4B | $17.8B | $5.5B | $3.3B | $3.1B |
| EBITDAEarnings before interest/tax | $588M | $2.7B | $465M | $572M | $381M |
| Net IncomeAfter-tax profit | -$1.1B | $1.5B | $134M | -$76M | -$205M |
| Free Cash FlowCash after capex | -$215M | $894M | $117M | $208M | $56M |
| Gross MarginGross profit ÷ Revenue | +56.2% | +67.6% | +10.6% | +22.8% | +13.5% |
| Operating MarginEBIT ÷ Revenue | +11.7% | +11.5% | +5.8% | +11.8% | +1.3% |
| Net MarginNet income ÷ Revenue | -32.8% | +8.6% | +2.4% | -2.3% | -6.6% |
| FCF MarginFCF ÷ Revenue | -6.4% | +5.0% | +2.1% | +6.2% | +1.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.6% | +9.6% | +5.0% | +4.5% | -2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -49.8% | +17.7% | -18.2% | +6.7% | +89.3% |
Valuation Metrics
Evenly matched — UHS and SEM and SGRY each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 7.3x trailing earnings, UHS trades at a 48% valuation discount to SEM's 13.9x P/E. On an enterprise value basis, UHS's 6.1x EV/EBITDA is more attractive than BKD's 25.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.3B | $10.5B | $2.0B | $1.9B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $4.9B | $15.9B | $5.7B | $5.7B | $9.8B |
| Trailing P/EPrice ÷ TTM EPS | -2.08x | 7.29x | 13.92x | -23.92x | -12.77x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.98x | 7.21x | 13.06x | 38.73x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 0.46x | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.40x | 6.09x | 12.04x | 10.03x | 25.92x |
| Price / SalesMarket cap ÷ Revenue | 0.70x | 0.61x | 0.37x | 0.57x | 1.08x |
| Price / BookPrice ÷ Book value/share | 1.07x | 1.47x | 1.00x | 0.53x | — |
| Price / FCFMarket cap ÷ FCF | — | 12.42x | 5.32x | 9.65x | — |
Profitability & Efficiency
UHS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
UHS delivers a 20.7% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-235 for BKD. UHS carries lower financial leverage with a 0.74x debt-to-equity ratio, signaling a more conservative balance sheet compared to SEM's 1.82x. On the Piotroski fundamental quality scale (0–9), UHS scores 6/9 vs BKD's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -40.9% | +20.7% | +6.6% | -2.4% | -234.5% |
| ROA (TTM)Return on assets | -18.6% | +9.8% | +2.3% | -0.9% | -3.4% |
| ROICReturn on invested capital | +5.9% | +12.3% | +4.8% | +4.1% | +0.2% |
| ROCEReturn on capital employed | +7.5% | +16.0% | +7.0% | +5.2% | +0.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 5 | 4 |
| Debt / EquityFinancial leverage | 1.24x | 0.74x | 1.82x | 1.14x | — |
| Net DebtTotal debt minus cash | $2.5B | $5.4B | $3.7B | $3.8B | $6.4B |
| Cash & Equiv.Liquid assets | $133M | $138M | $27M | $240M | $279M |
| Total DebtShort + long-term debt | $2.7B | $5.5B | $3.7B | $4.0B | $6.7B |
| Interest CoverageEBIT ÷ Interest expense | -5.99x | 10.92x | 4.41x | 1.35x | -0.03x |
Total Returns (Dividends Reinvested)
BKD leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BKD five years ago would be worth $21,485 today (with dividends reinvested), compared to $2,808 for SGRY. Over the past 12 months, BKD leads with a +110.1% total return vs SGRY's -36.6%. The 3-year compound annual growth rate (CAGR) favors BKD at 52.6% vs ACHC's -28.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +77.0% | -23.3% | +11.3% | -4.4% | +30.8% |
| 1-Year ReturnPast 12 months | +6.3% | -8.1% | +15.4% | -36.6% | +110.1% |
| 3-Year ReturnCumulative with dividends | -63.3% | +19.3% | +7.3% | -58.4% | +255.4% |
| 5-Year ReturnCumulative with dividends | -60.4% | +11.7% | -15.1% | -71.9% | +114.8% |
| 10-Year ReturnCumulative with dividends | -56.7% | +30.4% | +163.0% | +4.9% | -21.8% |
| CAGR (3Y)Annualised 3-year return | -28.4% | +6.1% | +2.4% | -25.3% | +52.6% |
Risk & Volatility
SEM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SEM is the less volatile stock with a 0.46 beta — it tends to amplify market swings less than SGRY's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SEM currently trades 96.7% from its 52-week high vs SGRY's 60.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.84x | 0.60x | 0.46x | 1.04x | 0.67x |
| 52-Week HighHighest price in past year | $30.20 | $246.33 | $16.99 | $24.18 | $17.00 |
| 52-Week LowLowest price in past year | $11.43 | $152.33 | $11.65 | $11.41 | $6.07 |
| % of 52W HighCurrent price vs 52-week peak | +83.8% | +68.4% | +96.7% | +60.3% | +83.4% |
| RSI (14)Momentum oscillator 0–100 | 46.1 | 35.2 | 62.9 | 59.0 | 51.2 |
| Avg Volume (50D)Average daily shares traded | 3.3M | 791K | 2.1M | 1.6M | 3.2M |
Analyst Outlook
Evenly matched — ACHC and UHS and SEM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ACHC as "Buy", UHS as "Hold", SEM as "Hold", SGRY as "Buy", BKD as "Buy". Consensus price targets imply 37.4% upside for UHS (target: $232) vs -7.1% for ACHC (target: $24). For income investors, SEM offers the higher dividend yield at 1.55% vs UHS's 0.47%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $23.50 | $231.50 | $18.00 | $18.60 | $17.67 |
| # AnalystsCovering analysts | 25 | 43 | 13 | 22 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | +0.5% | +1.5% | — | — |
| Dividend StreakConsecutive years of raises | 1 | 1 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $0.80 | $0.25 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +9.2% | +4.9% | 0.0% | +0.2% |
UHS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BKD leads in 1 (Total Returns). 2 tied.
ACHC vs UHS vs SEM vs SGRY vs BKD: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ACHC or UHS or SEM or SGRY or BKD a better buy right now?
For growth investors, Universal Health Services, Inc.
(UHS) is the stronger pick with 9. 7% revenue growth year-over-year, versus 4. 8% for Brookdale Senior Living Inc. (BKD). Universal Health Services, Inc. (UHS) offers the better valuation at 7. 3x trailing P/E (7. 2x forward), making it the more compelling value choice. Analysts rate Acadia Healthcare Company, Inc. (ACHC) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACHC or UHS or SEM or SGRY or BKD?
On trailing P/E, Universal Health Services, Inc.
(UHS) is the cheapest at 7. 3x versus Select Medical Holdings Corporation at 13. 9x. On forward P/E, Universal Health Services, Inc. is actually cheaper at 7. 2x.
03Which is the better long-term investment — ACHC or UHS or SEM or SGRY or BKD?
Over the past 5 years, Brookdale Senior Living Inc.
(BKD) delivered a total return of +114. 8%, compared to -71. 9% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: SEM returned +163. 0% versus ACHC's -56. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACHC or UHS or SEM or SGRY or BKD?
By beta (market sensitivity over 5 years), Select Medical Holdings Corporation (SEM) is the lower-risk stock at 0.
46β versus Surgery Partners, Inc. 's 1. 04β — meaning SGRY is approximately 127% more volatile than SEM relative to the S&P 500. On balance sheet safety, Universal Health Services, Inc. (UHS) carries a lower debt/equity ratio of 74% versus 182% for Select Medical Holdings Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ACHC or UHS or SEM or SGRY or BKD?
By revenue growth (latest reported year), Universal Health Services, Inc.
(UHS) is pulling ahead at 9. 7% versus 4. 8% for Brookdale Senior Living Inc. (BKD). On earnings-per-share growth, the picture is similar: Surgery Partners, Inc. grew EPS 54. 1% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, SGRY leads at 9. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ACHC or UHS or SEM or SGRY or BKD?
Universal Health Services, Inc.
(UHS) is the more profitable company, earning 8. 6% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SGRY leads at 11. 8% versus 0. 5% for BKD. At the gross margin level — before operating expenses — UHS leads at 90. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ACHC or UHS or SEM or SGRY or BKD more undervalued right now?
On forward earnings alone, Universal Health Services, Inc.
(UHS) trades at 7. 2x forward P/E versus 38. 7x for Surgery Partners, Inc. — 31. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UHS: 37. 4% to $231. 50.
08Which pays a better dividend — ACHC or UHS or SEM or SGRY or BKD?
In this comparison, SEM (1.
5% yield), UHS (0. 5% yield) pay a dividend. ACHC, SGRY, BKD do not pay a meaningful dividend and should not be held primarily for income.
09Is ACHC or UHS or SEM or SGRY or BKD better for a retirement portfolio?
For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
46), 1. 5% yield, +163. 0% 10Y return). Both have compounded well over 10 years (SEM: +163. 0%, SGRY: +4. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ACHC and UHS and SEM and SGRY and BKD?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ACHC is a small-cap quality compounder stock; UHS is a mid-cap deep-value stock; SEM is a small-cap deep-value stock; SGRY is a small-cap quality compounder stock; BKD is a small-cap quality compounder stock. SEM pays a dividend while ACHC, UHS, SGRY, BKD do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.